Carolinas Wealth Consulting »

Heron Therapeutics shares owned by Carolinas Wealth Consulting

Quarter-by-quarter ownership of Heron Therapeutics (HRTX) shares owned by Carolinas Wealth Consulting from 13F filings

Historical chart of Carolinas Wealth Consulting investment in Heron Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Heron Therapeutics held by Carolinas Wealth Consulting consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Heron Therapeutics by Carolinas Wealth Consulting

Quarter filed Position value Share count Share price at filing
2024-09-30 $55k 28k 1.99
2024-06-30 $76k 22k 3.50
2024-03-31 $55k 20k 2.77

More positions owned by Carolinas Wealth Consulting

Vanguard Scottsdale Fds Vng Rus1000grw (VONG)
Vanguard Bd Index Fds Intermed Term (BIV)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Schwab Strategic Tr Us Dividend Eq (SCHD)
Ishares Tr Rus 1000 Grw Etf (IWF)
Vanguard Scottsdale Fds Vng Rus1000val (VONV)
Apple (AAPL)
Vanguard Specialized Funds Div App Etf (VIG)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Ishares Tr Rus 1000 Val Etf (IWD)
Microsoft Corporation (MSFT)
Vanguard Admiral Fds Smllcp 600 Idx (VIOO)
Ishares Tr Rus 2000 Val Etf (IWN)
J P Morgan Exchange Traded F Ultra Shrt Etf (JPST)
Berkshire Hathaway Inc Del Cl A (BRK.A)

View all positions for Carolinas Wealth Consulting

Top funds holding Heron Therapeutics

Rubric Capital Management
Vanguard Group
BlackRock
BlackRock
Tejara Capital
State Street Corporation
D. E. Shaw & Co
Palisade Capital Management
Geode Capital Management
JW Asset Management
Clearline Capital
Renaissance Technologies
Orchard Capital Managment
Congress Park Capital
Tang Capital Management

View all funds holding Heron Therapeutics